Pneumococcal conjugate second or third-dose vaccines (PCVc) in World
World: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 71.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in World, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in World is 71.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 2.9% on the previous year and up 86.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in World peaked at 71.0% in 2025 and was at its lowest, 4.0%, in 2008.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in World, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 4.0% | — |
| 2009 | 6.0% | +50.0% |
| 2010 | 10.0% | +66.7% |
| 2011 | 15.0% | +50.0% |
| 2012 | 19.0% | +26.7% |
| 2013 | 26.0% | +36.8% |
| 2014 | 32.0% | +23.1% |
| 2015 | 38.0% | +18.8% |
| 2016 | 41.0% | +7.9% |
| 2017 | 45.0% | +9.8% |
| 2018 | 48.0% | +6.7% |
| 2019 | 51.0% | +6.2% |
| 2020 | 52.0% | +2.0% |
| 2021 | 51.0% | -1.9% |
| 2022 | 60.0% | +17.6% |
| 2023 | 66.0% | +10.0% |
| 2024 | 69.0% | +4.5% |
| 2025 | 71.0% | +2.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.0% | 4.0% | 6.0% | 2 |
| 2010s | 32.5% | 10.0% | 51.0% | 10 |
| 2020s | 61.5% | 51.0% | 71.0% | 6 |
More health data for World
- Neonatal tetanus - number of reported cases, gaps filled 2,458 (2025)
- Population ages 00-04, female, annual growth rate -0.47 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0381 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.6031 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0401 units per person (2025)
- Population ages 05-09, female, annual growth rate -0.915 % change on previous year (2025)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.04 units per person (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in World?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in World was 71.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in World?
- The highest recorded value was 71.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in World?
- The lowest recorded value was 4.0% in 2008.
- How does World rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- World ranks 7th out of 11 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in World?
- Over the last ten years it is up 86.8%. The long-run trend across the full record is volatile.
- Where does this World data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).